Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Digestive Diseases and Sciences
Erschienen in: Digestive Diseases and Sciences 11/2011

01.11.2011 | Brief Communication

Liver Transplantation Trends in the HIV Population

verfasst von: Nyingi M. Kemmer, Kenneth E. Sherman

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

There is a paucity of information on the utilization patterns of liver transplantation (LT) for HIV-positive individuals. The aim of this study is to examine the trends in LT of HIV patients in the US. This study was a retrospective analysis using the UNOS database (1999–2008). There were 135 HIV-positive patients. There was a steady increase in the number of LT recipients over time as well as regional variation. Ethnic minorities accounted for 33.3% and there was no ethnic difference in survival. Though LT for HIV-positive patients is on the rise, significant variations exist in patient demographics, geographic location, and insurance payer.
Literatur
1.
Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166:1632–1641.PubMedCrossRef
2.
Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis c virus-related decompensated cirrhosis. Hepatology. 2005;41:779–789.PubMedCrossRef
3.
Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network of Organ Sharing database. Transplantation. 2008;85:359–368.PubMedCrossRef
4.
Norris S, Taylor C, Muiesan P, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl. 2004;10:1271–1278.PubMedCrossRef
5.
Duclos-Vallee JC, Teicher E, Vittecoq D, Samuel D. Liver transplantation for patients infected with both HIV and HCV or HIV and HBV. Med Sci (Paris). 2007;23:723–728.CrossRef
6.
Roland ME, Barin B, Carlson L, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transpl. 2008;8:355–365.CrossRef
7.
Stock PG, Roland ME. Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation. 2007;84:563–571.PubMedCrossRef
8.
9.
Sherman KE, Peters M, Koziel MJ. HIV and liver disease forum: conference proceedings. Hepatology. 2007;45:1566–1577.PubMedCrossRef
10.
Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992–2001. Arch Intern Med. 2004;164:2349–2354.PubMedCrossRef
11.
Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med. 2008;148:728–736.PubMed
12.
Castellares C, Barreiro P, Martin-Carbonero L, et al. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat. 2008;15:165–172.PubMed
13.
Rodriguez-Torres M, Govindarajan S, Diago M, et al. Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40 kD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks. Liver Int. 2009;29:237–241.PubMedCrossRef
14.
Martin-Carbonero L, de Ledinghen V, Moreno A, et al. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. J Viral Hepat. 2009;16:790–795.PubMedCrossRef
15.
Sulkowski MS, Mehta SH, Torbenson MS, et al. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS. 2007;21:2209–2216.PubMedCrossRef
16.
Yoo HY, Galabova V, Edwin D, Thuluvath PJ. Socioeconomic status does not affect the outcome of liver transplantation. Liver Transpl. 2002;8:1133–1137.PubMedCrossRef
17.
Kemmer N, Zacharias V, Kaiser TE, Neff GW. Access to liver transplantation in the meld era: role of ethnicity and insurance. Dig Dis Sci. 2008;54:1794–1797.PubMedCrossRef
18.
Thamer M, Henderson SC, Ray NF, Rinehart CS, Greer JW, Danovitch GM. Unequal access to cadaveric kidney transplantation in California based on insurance status. Health Serv Res. 1999;34:879–900.PubMed
19.
Winkelmayer WC, Glynn RJ, Levin R, Owen W Jr, Avorn J. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001;60:1547–1554.PubMedCrossRef
20.
Cass A, Cunningham J, Snelling P, Ayanian JZ. Late referral to a nephrologist reduces access to renal transplantation. Am J Kidney Dis. 2003;42:1043–1049.PubMedCrossRef
21.
Kemmer N, Safdar K, Kaiser T, Zacharias V, Neff GW. Impact of geographic location on access to liver transplantation among ethnic minorities. Transplantation. 2008;85:166–170.PubMedCrossRef
22.
Muir AJ, Sanders LL, Heneghan MA, Kuo PC, Wilkinson WE, Provenzale D. An examination of factors predicting prioritization for liver transplantation. Liver Transpl. 2002;8:957–961.PubMedCrossRef
23.
McCormick PA, O’Rourke M, Carey D, Laffoy M. Ability to pay and geographical proximity influence access to liver transplantation even in a system with universal access. Liver Transpl. 2004;10:1422–1427.PubMedCrossRef
24.
Gill JS, Hussain S, Rose C, Hariharan S, Tonelli M. Access to kidney transplantation among patients insured by the United States department of veterans affairs. J Am Soc Nephrol. 2007;18:2592–2599.PubMedCrossRef
25.
Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl. 2004;10:235–243.PubMedCrossRef
26.
Heslin KC, Andersen RM, Ettner SL, Cunningham WE. Racial and ethnic disparities in access to physicians with HIV-related expertise. J Gen Intern Med. 2005;20:283–289.PubMedCrossRef
27.
28.
Kroeker KI, Bain VG, Shaw-Stiffel T, Fong TL, Yoshida EM. Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007. Liver Int. 2008;28:1250–1255.PubMedCrossRef
29.
Cooper CL, DeForest J, Gill J, Lalonde R. Barriers preventing liver transplantation in Canadians with HIV-infection–perceptions of HIV specialists. Can J Gastroenterol. 2007;21:179–182.PubMed
30.
Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E. Determinants of transplant surgeons’ willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transpl. 2005;5:1319–1325.CrossRef
31.
Kemmer N, Safdar K, Kaiser TE, Zacharias V, Neff GW. Liver transplantation trends for older recipients: regional and ethnic variations. Transplantation. 2008;86:104–107.PubMedCrossRef
32.
Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the meld score. JAMA. 2008;300:2371–2378.PubMedCrossRef
33.
Reid AE, Resnick M, Chang Y, Buerstatte N, Weissman JS. Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl. 2004;10:834–841.PubMedCrossRef
34.
French AL, Gawel SH, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51:399–406.PubMedCrossRef
35.
Whitmore SK, Satcher AJ, Hu S. Epidemiology of HIV/aids among non-Hispanic black women in the United States. J Natl Med Assoc. 2005;97:19S–24S.PubMed
36.
Arya M, Behforouz HL, Viswanath K. African American women and HIV/aids: a national call for targeted health communication strategies to address a disparity. AIDS Read. 2009;19:79–84.PubMed
37.
Smith AK, Ladner D, McCarthy EP. Racial/ethnic disparities in liver transplant surgery and hospice use: parallels, differences, and unanswered questions. Am J Hosp Palliat Care. 2008;25:285–291.PubMedCrossRef
38.
Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet. 2002;359:287–293.PubMedCrossRef
39.
Ananthakrishnan AN, Saeian K. Racial differences in liver transplantation outcomes in the meld era. Am J Gastroenterol. 2008;103:901–910.PubMedCrossRef
40.
Costigliola P, Tumietto F, Zagnoli A, Chiodo F. Need for liver transplant in HIV-positive patients: first results of a specific survey in Italy, project host. AIDS. 2003;17:2119–2121.PubMedCrossRef
41.
Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl. 2005;11:1425–1430.PubMedCrossRef
42.
Vibert E, Duclos-Vallee JC, Ghigna MR, et al. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology. 2011;53:475–482.PubMedCrossRef
43.
Baccarani U, Adani GL, Tavio M, Viale P. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection–21 plus 13. Hepatology. 2011;53:2138. author reply 2138–2139.PubMedCrossRef
44.
Miro JM, Torre-Cisnero J, Moreno A, et al. GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005). Enferm Infecc Microbiol Clin. 2005;23:353–362.PubMedCrossRef
45.
O’Grady J, Taylor C, Brook G. Guidelines for liver transplantation in patients with HIV infection (2005). HIV Med. 2005;6:149–153.PubMedCrossRef
46.
Baccarani U, Adani GL, Bragantini F, et al. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases. Transpl Proc. 2011;43:1119–1122.CrossRef
47.
Di Benedetto F, Tarantino G, De Ruvo N, et al. University of Modena experience in HIV-positive patients undergoing liver transplantation. Transpl Proc. 2011;43:1114–1118.CrossRef
Metadaten
Titel
Liver Transplantation Trends in the HIV Population
verfasst von
Nyingi M. Kemmer
Kenneth E. Sherman
Publikationsdatum
01.11.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1867-8

Weitere Artikel der Ausgabe 11/2011

Digestive Diseases and Sciences 11/2011 Zur Ausgabe

Original Article

The Causes and Outcome of Acute Pancreatitis Associated with Serum Lipase >10,000 U/L

Original Article

The Management of Chronic Hepatitis B in Asian Americans

Case Report

Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case

Original Article

Serotonin Transporter and G Protein Beta 3 Subunit Gene Polymorphisms in Greeks with Irritable Bowel Syndrome

Editorial

Access to Care and Optimal Treatment of Chronic Hepatitis B in Asian Americans: An Evolving Agenda

Original Article

Effect of Red Pepper on Symptoms of Irritable Bowel Syndrome: Preliminary Study

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise